Talk Business of Biotech track
Pharma Presentation: Debiopharm International SA
Tue, Nov 10, 2026 · 10:15–10:30 AM CET Business of Biotech Stage, Koelnmesse
About this session
Debiopharm, a privately owned Swiss-based biopharmaceutical company, focuses on developing innovative therapies that target high unmet medical needs in oncology and bacterial infections. Bridging the gap between disruptive discovery products and real-world patient reach, we identify high-potential compounds for in-licensing, clinically demonstrate their safety and efficacy and then select large pharmaceutical commercialization partners to maximize patient access globally.
Speaker
-
Partnering Manager - Search & Evaluation · Debiopharm International SA
Speaker